Loading, please wait ...

News Analytics

The Mark Foundation for Cancer Research and the Bloomberg~Kimmel Institute for Cancer Immunotherapy (BKI) announced today a new $10 million commitment at The Johns Hopkins University to fund novel work and advance immunotherapy research to provide lifesaving breakthroughs to people with cancer. Immunotherapy drugs — more than all other cancer drugs approved in the last decade — are now becoming first-line therapies.

The Angle

Subject Matter

  • Healthcare 58.23%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 41.77%

Emotional Reaction






Depth Chart

Here we provide depth for the multitude of dimensions lacing this article.

Connect your favorite information below with the lead sentence at the top of the page to build a mental model of the story.